BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 15590853)

  • 1. Diagnostic value and limitations of fluorine-18 fluorodeoxyglucose positron emission tomography for cartilaginous tumors of bone.
    Lee FY; Yu J; Chang SS; Fawwaz R; Parisien MV
    J Bone Joint Surg Am; 2004 Dec; 86(12):2677-85. PubMed ID: 15590853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18FDG-PET applications for cartilage neoplasms.
    Feldman F; Van Heertum R; Saxena C; Parisien M
    Skeletal Radiol; 2005 Jul; 34(7):367-74. PubMed ID: 15937711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG-PET in differential diagnosis and grading of chondrosarcomas.
    Aoki J; Watanabe H; Shinozaki T; Tokunaga M; Inoue T; Endo K
    J Comput Assist Tomogr; 1999; 23(4):603-8. PubMed ID: 10433294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of histopathologic and radiologic grading of cartilaginous neoplasms in long bones.
    Skeletal Lesions Interobserver Correlation among Expert Diagnosticians (SLICED) Study Group
    J Bone Joint Surg Am; 2007 Oct; 89(10):2113-23. PubMed ID: 17908885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Thallium-201 scintigraphy and Tc-99m pentavalent dimercaptosuccinic acid in diagnosis and grading of chondrosarcoma.
    Jo O; Schlicht S; Slavin J; Di Bella C; Pang G; Powell G; Spelman T; Choong PF
    Eur J Radiol; 2020 Apr; 125():108846. PubMed ID: 32062570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F-18 FDG PET differentiation of benign from malignant chondroid neoplasms: a systematic review of the literature.
    Subhawong TK; Winn A; Shemesh SS; Pretell-Mazzini J
    Skeletal Radiol; 2017 Sep; 46(9):1233-1239. PubMed ID: 28608242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
    Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
    Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of
    Zhang Q; Xi Y; Li D; Yuan Z; Dong J
    J Orthop Surg Res; 2020 Jun; 15(1):229. PubMed ID: 32571371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Skeletal Imaging Essential in the Staging Workup for Conventional Chondrosarcoma?
    Gulia A; Kurisunkal V; Puri A; Purandare N; Gupta S; Rangarajan Drm V
    Clin Orthop Relat Res; 2020 Nov; 478(11):2480-2484. PubMed ID: 32567825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scintigraphy of benign exostoses and exostotic chondrosarcomas.
    Hudson TM; Chew FS; Manaster BJ
    AJR Am J Roentgenol; 1983 Mar; 140(3):581-6. PubMed ID: 6600555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients.
    Brenner W; Conrad EU; Eary JF
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):189-95. PubMed ID: 15129700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cartilage tumors : Pathology and radiomorphology].
    Uhl M; Herget G; Kurz P
    Radiologe; 2016 Jun; 56(6):476-88. PubMed ID: 27233920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor grade-related thallium-201 uptake in chondrosarcomas.
    Kaya GC; Demir Y; Ozkal S; Sengoz T; Manisali M; Baran O; Koc M; Tuna B; Ozaksoy D; Havitcioglu H
    Ann Nucl Med; 2010 May; 24(4):279-86. PubMed ID: 20238186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiographic Enchondroma Surveillance: Assessing Clinical Outcomes and Costs Effectiveness.
    Akoh CC; Craig E; Troester AM; Miller BJ
    Iowa Orthop J; 2019; 39(1):185-193. PubMed ID: 31413693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of cartilaginous tumors with 201Tl scintigraphy.
    Higuchi T; Taki J; Sumiya H; Kinuya S; Nakajima K; Namura M; Tonami N
    Ann Nucl Med; 2005 Apr; 19(2):95-9. PubMed ID: 15909488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curettage and cryosurgery for low-grade cartilage tumors is associated with low recurrence and high function.
    Mohler DG; Chiu R; McCall DA; Avedian RS
    Clin Orthop Relat Res; 2010 Oct; 468(10):2765-73. PubMed ID: 20574801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary chondrosarcoma in cartilage bone tumors: report of 32 patients.
    Altay M; Bayrakci K; Yildiz Y; Erekul S; Saglik Y
    J Orthop Sci; 2007 Sep; 12(5):415-23. PubMed ID: 17909925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Needle Biopsy Clinically Useful in Preoperative Grading of Central Chondrosarcoma of the Pelvis and Long Bones?
    Roitman PD; Farfalli GL; Ayerza MA; Múscolo DL; Milano FE; Aponte-Tinao LA
    Clin Orthop Relat Res; 2017 Mar; 475(3):808-814. PubMed ID: 26883651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiographic hallmarks of peripheral chondrosarcoma.
    Norman A; Sissons HA
    Radiology; 1984 Jun; 151(3):589-96. PubMed ID: 6718712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved differentiation of benign osteochondromas from secondary chondrosarcomas with standardized measurement of cartilage cap at CT and MR imaging.
    Bernard SA; Murphey MD; Flemming DJ; Kransdorf MJ
    Radiology; 2010 Jun; 255(3):857-65. PubMed ID: 20392983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.